EGFR: Clinical Trials

1 trial for EGFR, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow EGFR: new trials by email Literature Review of EGFR trials Research Report on EGFR

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer
BIBW 2992 - Non-Small Cell Lung Cancer, EGFR
Phase 2CompletedInstituto Nacional de Cancerologia de Mexico662012-01-012024-02-06

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)

Broader conditions

Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Afatinib (1)

Sponsors

Instituto Nacional de Cancerologia de Mexico (1)

Countries

Mexico (1)

Top investigators

Oscar Arrieta, MD M Sc (1)

Results publications

PMID 27033062